» Articles » PMID: 37369679

K235 Acetylation Couples with PSPC1 to Regulate the MA Demethylation Activity of ALKBH5 and Tumorigenesis

Overview
Journal Nat Commun
Specialty Biology
Date 2023 Jun 27
PMID 37369679
Authors
Affiliations
Soon will be listed here.
Abstract

N6-methyladenosine (mA) modification plays important roles in bioprocesses and diseases. AlkB homolog 5 (ALKBH5) is one of two mA demethylases. Here, we reveal that ALKBH5 is acetylated at lysine 235 (K235) by lysine acetyltransferase 8 and deacetylated by histone deacetylase 7. K235 acetylation strengthens the mA demethylation activity of ALKBH5 by increasing its recognition of mA on mRNA. RNA-binding protein paraspeckle component 1 (PSCP1) is a regulatory subunit of ALKBH5 and preferentially interacts with K235-acetylated ALKBH5 to recruit and facilitate the recognition of mA mRNA by ALKBH5, thereby promoting mA erasure. Mitogenic signals promote ALKBH5 K235 acetylation. K235 acetylation of ALKBH5 is upregulated in cancers and promotes tumorigenesis. Thus, our findings reveal that the mA demethylation activity of ALKBH5 is orchestrated by its K235 acetylation and regulatory subunit PSPC1 and that K235 acetylation is necessary for the mA demethylase activity and oncogenic roles of ALKBH5.

Citing Articles

m6A RNA methylation: a pivotal regulator of tumor immunity and a promising target for cancer immunotherapy.

Chen X, Yuan Y, Zhou F, Li L, Pu J, Jiang X J Transl Med. 2025; 23(1):245.

PMID: 40022120 PMC: 11871626. DOI: 10.1186/s12967-025-06221-y.


m6A eraser ALKBH5/treRNA1/DDX46 axis regulates BCR expression.

Kapadia B, Roychowdhury A, Kayastha F, Lee W, Nanaji N, Windle J Neoplasia. 2025; 62:101144.

PMID: 39987653 PMC: 11905846. DOI: 10.1016/j.neo.2025.101144.


Cellular senescence: from homeostasis to pathological implications and therapeutic strategies.

Li C, Yuan Y, Jia Y, Zhou Q, Wang Q, Jiang X Front Immunol. 2025; 16:1534263.

PMID: 39963130 PMC: 11830604. DOI: 10.3389/fimmu.2025.1534263.


Dynamic multilayered control of mA RNA demethylase activity.

Jaafar C, Aguiar R Proc Natl Acad Sci U S A. 2024; 121(46):e2317847121.

PMID: 39495907 PMC: 11572932. DOI: 10.1073/pnas.2317847121.


RNA modification in normal hematopoiesis and hematologic malignancies.

Chen X, Yuan Y, Zhou F, Li L, Pu J, Jiang X MedComm (2020). 2024; 5(11):e787.

PMID: 39445003 PMC: 11496571. DOI: 10.1002/mco2.787.


References
1.
Huang J, Chen M, Chen D, Gao X, Zhu S, Huang H . A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth. Mol Cell. 2017; 68(1):171-184.e6. DOI: 10.1016/j.molcel.2017.09.015. View

2.
Yoon S, Eom G . HDAC and HDAC Inhibitor: From Cancer to Cardiovascular Diseases. Chonnam Med J. 2016; 52(1):1-11. PMC: 4742605. DOI: 10.4068/cmj.2016.52.1.1. View

3.
Jin D, Guo J, Wu Y, Yang L, Wang X, Du J . mA demethylase ALKBH5 inhibits tumor growth and metastasis by reducing YTHDFs-mediated YAP expression and inhibiting miR-107/LATS2-mediated YAP activity in NSCLC. Mol Cancer. 2020; 19(1):40. PMC: 7045432. DOI: 10.1186/s12943-020-01161-1. View

4.
Yang Y, Hsu P, Chen Y, Yang Y . Dynamic transcriptomic mA decoration: writers, erasers, readers and functions in RNA metabolism. Cell Res. 2018; 28(6):616-624. PMC: 5993786. DOI: 10.1038/s41422-018-0040-8. View

5.
Xu S, Huang J, Xu M, Yu G, Yin X, Chen D . ACK1 promotes gastric cancer epithelial-mesenchymal transition and metastasis through AKT-POU2F1-ECD signalling. J Pathol. 2015; 236(2):175-85. DOI: 10.1002/path.4515. View